摘要
目的:探讨胃癌cerbB2及增殖细胞核抗原(PCNA)表达与预后的关系。方法:应用免疫组化ABC法对103例胃癌胃镜活检组织进行检测。结果:分别有19例与53例出现cerbB2阳性表达及高PCNA阳性标记(>3561%),两者表达与胃癌大体类型、进展程度、组织类型、分化程度及有无伴淋巴结及肝转移情况密切相关。高PCNA阳性标记者cerbB2表达阳性率高,5年生存率低;高中分化胃癌中,cerbB2表达阳性者5年生存率显著低于阴性者。
Aim: To study the prognostic significance of expression of cerbB2 and proliferating cell nuclear antigen (PCNA) in gastric cancer. Method: Immunohistochemical reactivity to cerbB2 protein and PCNA was examined in bioptic specimens from endoscopy of 103 patients with gastric cancer.Results: 19 and 53 cases of 103 patients were positive for cerbB2 expression and high PCNA labeling index(>35.61%)respectively. There were significant differences in morphologic type,depth of tumor invasion,histology,differentiation,lymph node and liver metastasis between positive and negative cerbB2 expression,high and low PCNA labeling index groups.The incidence of cerbB2 positivity was significantly higher in high PCNA index group which had poorer 5-year survival rates than in low PCNA index group. Patients with cerbB2-positive tumors had poorer 5-year survival rates than those with cerbB2-negative ones in the well to moderately differentiated carcinoma. Conclusions:The results showed that the cerbB2 and PCNA expression was a helpful prognostic factor for gastric cancer.
出处
《胃肠病学和肝病学杂志》
CAS
1998年第1期30-33,共4页
Chinese Journal of Gastroenterology and Hepatology
关键词
C-ERBB-2
增殖细胞核抗原
预后
胃肿瘤
Gastric cancer CerbB2 protein Proliferating cell nuclear antigen Prognosis